Deal Corners

HTML PDF


Deal Corner January 20, 2017

MSD divests 6 brands to Zydus Healthcare Limited

DEAL BRIEF

United States pharmaceutical giant Merck & Co., Inc. (known as Merck Sharp & Dohme (MSD) outside the United States and Canada), through its subsidiaries, divested its 6 brands to Zydus Cadila’s wholly owned subsidiary Zydus Healthcare Limited. Pharmaceutical products in the segment of men’s and women’s health, wound management and cardiovascular therapy were sold under these brands.

In addition to the sale of brand names, Organon India Private Limited, an Indian subsidiary company of Merck & Co., Inc. /MSD, assigned manufacturing know-how, distribution and commercialization rights for 3 of the brands sold as part of the deal.

Press coverage relating to this transaction available at Business Standard, Economic Times, Live Mint and Pharma Biz.

OUR ROLE

We, at Nishith Desai Associates, acted as the Indian legal and regulatory counsel to MSD.


Nishith Desai Associates 2013. All rights reserved.